TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma
Clinical trial NCT07340502 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07340502
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-31
- Primary completion
- 2027-12-31
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.